T1	Participants 62 109	peripheral stage IA non-small cell lung cancer:
T2	Participants 334 378	patients with operable stage IA lung cancer.
T3	Participants 1013 1093	a planning study was performed in 26 stage I patients, of which 22 were stage 1A
